Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Aug
16
2024
Real-World Data Back in the Spotlight at FDA McDermott Will & Emery
Aug
16
2024
CMS Rules Propose Changes Regarding the Medicare Prescription Drug Inflation Rebate Program, Refundable Drugs, Skin Supplements and More; Comments Due September 9 Epstein Becker & Green, P.C.
Aug
16
2024
What To Expect for the IPO Market in the Second Half of 2024 Foley & Lardner LLP
Aug
15
2024
UPSIDE Sues Florida Over Cell-Grown Meat Ban Keller and Heckman LLP
Aug
15
2024
Recent Supreme Court Decisions and the DSCSA Epstein Becker & Green, P.C.
Aug
15
2024
FTC Releases Controversial Interim Staff Report on PBMs’ Purported Impact on Drug Prices Epstein Becker & Green, P.C.
Aug
15
2024
FDA Rolls Out Innovative New Designation Programs in Response to Congressional Mandates Mintz
Aug
15
2024
No Surprises Here! Fifth Circuit Upholds Health Care Provider Challenge to No Surprises Act Regulations Proskauer Rose LLP
Aug
14
2024
BIPA Update: Illinois Limits Liability and Clarifies Electronic Consent for Biometric Data Collection Greenberg Traurig, LLP
Aug
14
2024
This Week in 340B: August 6 – 12, 2024 McDermott Will & Emery
Aug
14
2024
Krazati Untitled Letter: A Cautionary Tale for CFL Promotion of Accelerated Approval Drugs Sheppard, Mullin, Richter & Hampton LLP
Aug
14
2024
NASEM Releases Report on Infant Formula Market Challenges Keller and Heckman LLP
Aug
14
2024
China’s State Administration for Market Regulation Releases Draft Antitrust Guidelines for the Pharmaceutical Sector Covering Reverse Payments and Evergreening Schwegman, Lundberg & Woessner, P.A.
Aug
13
2024
Bipartisan Legislation Would Advance American Production of Renewable Chemicals Bergeson & Campbell, P.C.
Aug
13
2024
Cancer Drugs: Antibody-Drug Conjugate Litigation Foley & Lardner LLP
Aug
13
2024
Illinois Judge Dismisses Bottled Water False Ad Complaint Keller and Heckman LLP
Aug
13
2024
Litigation Minute: Microplastics—Everything, Everywhere, All at Once? K&L Gates
Aug
12
2024
Alabama Awards Two Additional Cannabis Cultivation Licenses Bradley Arant Boult Cummings LLP
Aug
12
2024
New Maine Law Will Streamline Application Process for On-Premise Liquor License Pierce Atwood LLP
Aug
9
2024
Impact of Ohio Legal Recreational Marijuana on Employers: All Smoke and No Fire? Jackson Lewis P.C.
Aug
9
2024
APHIS Announces New Flexibility for BRS Importation Permits in APHIS eFile Bergeson & Campbell, P.C.
Aug
9
2024
FDA and CTTI Hold Joint Workshop on AI in Drug Development – AI: The Washington Report Mintz
Aug
9
2024
Department of Justice (DOJ) Launches Corporate Whistleblower Awards Pilot Program ArentFox Schiff LLP
Aug
9
2024
From Prescription Pad to Prison: Physician’s Opioid Scheme Leads to $4.7 Million Judgment Tycko & Zavareei LLP
Aug
8
2024
FDA Releases Summary Report on Fresh Herbs Sampling Assignment Keller and Heckman LLP
Aug
8
2024
5 Questions About Ketamine Investigations Answered Oberheiden P.C.
Aug
8
2024
HHS-OIG Draws Legal Boundaries for Patient Caregiver Support Provided by Biotech Company Barnes & Thornburg LLP
Aug
7
2024
FDA Will Hold Meeting in September 2024 on Development of Enhanced Systematic Process for Post-Market Assessment of Chemicals in Food, Announces Executive Career Opportunities Related to Human Foods Program Bergeson & Campbell, P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins